Indian Tree Bark Extract Oxyjun® Clinically Proven To Improve Cardio-Endurance in Athletes
According to a recent study conducted by the National Institute of Health, sudden cardiac death is the most common medical cause of death in athletes, with an incidence of around 1 in 40,000 to 1 in 80,000 athletes per year. Source
For decades, several medicinal plants have been known to treat, cure or prevent cardiac ailments using Ayurveda.
During past research, one particular extract from the Arjuna Bark (Terminalia arjuna), revealed its potential benefits for use in heart-health supplements.
Since then, Arjuna extract has been considered to be useful in preventing:
Coronary Artery Disease
Heart Disease & Failure
Anginal Coronary Artery Disease
At Enovate Biolife, we conducted a clinical study to prove that Oxyjun®, an extract developed by us from Arjuna Bark, increases cardiovascular efficiency, improves cardiac conditioning in young men and supports heart safety and performance in athletes.
Read ahead to learn more about how we harnessed the power of Arjuna to create Oxyjun®; an essential heart fuel for athletes.
What is Oxyjun®?
Oxyjun® is the only arjunolic acid-free and DNA-authenticated extract of Arjuna clinically proven to support heart health and cardio endurance for active adults. It is a proprietary extract of Terminalia arjuna, removed using a hydrothermal process (water at a specific temperature and pressure).
Oxyjun® has clinically proven heart health benefits in healthy adults which include:
Supporting normal heart muscle function
Improving heart pumping capacity
Allowing users to exercise longer with higher intensity without exhaustion
Enhancing performance by stronger contractions, ejection fractions and cardiac output
Increasing VO2max & reducing the rate of perceived exertion without any cardiac stress or injury
Why Do Athletes Require Oxyjun®?
While exercising, seemingly fit athletes are usually unaware of their low LVEF or Left Ventricular Ejection Fraction. A low LVEF spells trouble, indicating that the left ventricle is not contracting sufficiently to pump enough blood out of their hearts, leading to gradual heart failure.
Over the years, sudden cardiac death (SCD) is the most frequent medical cause of sudden death in athletes.
Clinically proven to increase cardiac outflow by increasing the pumping capacity of the heart, Oxyjun® effectively manages the ejection fraction, making a significant impact on the quality of athlete workouts and endurance.
It also assists sportspeople in strengthening their heart muscles, supporting healthy circulation, and promoting proper oxygenation through the body.
Oxyjun® can also be easily formulated into capsules, tablets, pre/post workout bars, powdered drinks and heart health support formulas.
Is Oxyjun® Suitable for Sportspeople Only?
While Oxyjun® is best suited to improve sports performance, all kinds of athletes; young, old, professionals, weekend warriors and serious sportspeople can make use of this heart supplement.
For a healthy heart formula, Oxyjun® can be combined with well-known ingredients like Coq10, Omega 3 to develop a complete cardiovascular health formula.
Oxyjun® is also an ideal fatigue-fighting fuel since it is proven to improve endurance, VO2max and reduce exertion.
What Are Its Clinically Proven Health Benefits?
Several clinical studies were undertaken to prove the effect of Oxyjun® on the heart health of athletes.
Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in young, healthy exercising adults.
Forty young subjects divided into four groups were administered Ashwagandha, Terminalia arjuna, placebo and combination of Ashwagandha & Terminalia Arjuna for eight weeks.
The volunteers receiving Terminalia arjuna demonstrated a significant increase in maximum oxygen consumption capacity (VO2 max). It also led to lowered systolic blood pressure. The average absolute power of the lower limbs also increased with Terminalia Arjuna.
Effect of E-OJ-01 on Cardiac Conditioning in Young Exercising Adults: A Randomized Controlled Trial published in the American Journal of Therapeutics. Source: